Here are four points:
1. Dr. Mascioli has more than 25 years of leadership experience, and he previously held the inaugural CMO position at Terumo Americas Holdings.
2. He has also served as CMO of the vascular therapies division of Covidien.
3. Mr. Alexander has more than 20 years of operational expertise in manufacturing and supply chain management.
4. He most recently served in various leadership roles at Genzyme, most recently heading Genzyme’s flagship biologics plant.
More articles on devices:
NuVasive to show Integrated Global Alignment platform at BritSpine: 3 takeaways
Analysts rate Exactech shares — 5 facts
Beyond the device: How DePuy Synthes is innovating in orthopedic & spine technology
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
